Data / Form D filings / GENEOS Therapeutics, Inc.
GENEOS Therapeutics, Inc.: Form D filings
GENEOS Therapeutics, Inc., a biotechnology company in Plymouth Meeting, PA, filed 4 Form D notices with the SEC between 2019 and 2023. The latest, on April 13, 2023, reports $5 million sold of a $10 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 660 WEST GERMANTOWN PIKE, SUITE LL110, Plymouth Meeting, PA, 19462
- Phone
- (267) 440-4232
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1769177
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 13, 2023 | New notice | $9,999,996 | $4,999,998 | $4,999,998 | 1 | Mar 31, 2023 | sec.gov |
| Mar 28, 2022 | New notice | $25,000,000 | $17,249,984 | $7,750,016 | 9 | Mar 21, 2022 | sec.gov |
| Nov 17, 2020 | New notice | $11,999,995 | $10,399,998 | $1,599,997 | 4 | Nov 12, 2020 | sec.gov |
| Feb 27, 2019 | New notice | $10,499,993 | $4,499,998 | $5,999,995 | 3 | Feb 21, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Laurent Y. Humeau | Director | |
| James Y. Eadie | Director | |
| Niranjan Y. Sardesai | Executive Officer, Director | |
| Samuel Y. Broder | Director | |
| Sangwoo Y. Lee | Director | |
| Casey Y. Cunningham | Director | |
| Ted Y. Fjallman | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Apr 10, 2023 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GENEOS Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.